#ExistInterpData>Refer to report.
For additional information, refer to the Breast Cancer Management Assays, Prostate Cancer, or Colorectal Cancer topic at arupconsult.com.
||The CellSearch™ Circulating Tumor Cell kit is intended for the quantification of circulating tumor cells (CTC) of epithelial origin for metastatic breast, colon, or prostate cancer, in whole blood. This assay can be used to predict progression free and overall survival in patients treated for metastatic cancer.
The results of a CellSearch™ test should be interpreted with caution if specimens are drawn within 7 days of administration of doxorubicin therapy.
||Circulating Tumor Cells, Breast, Colon, Prostate (Circulating Tumor Cell Count (Cell Search))
, CTC (Circulating Tumor Cell Count (Cell Search))